Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 kinase

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 744-751

  Bae, Jong Sup ^a   Kim, Yong Ung ^a   Park, Moon Ki ^a   Rezaie, Alireza R ^b  

^a Daegu Haany University   (South Korea)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; CELL ADHESION MOLECULE; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGOPEPTIDE; THREONYL PHENYLALANYL LEUCYL LEUCYL ARGINYL ASPARAGINE; THREONYL-PHENYLALANYL-LEUCYL-LEUCYL-ARGINYL-ASPARAGINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL STIMULATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CELL ADHESION MOLECULES; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; NEUTROPHILS; OLIGOPEPTIDES; RECEPTOR, PAR-1; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64549153208     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21718     Document Type: Article

References (59)

1. Akeson AL, Woods CW. 1993. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods 163:181-185. (Pubitemid 23248392)
2. Arena CS, Quirk SM, Zhang YQ, Henrikson KP. 1996. Rat uterine stromal cells: Thrombin receptor and growth stimulation by thrombin. Endocrinology 137:3744-3749. (Pubitemid 26284641)
3. Bae JS, Rezaie AR. 2008. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost 100:101-109.
4. Bae JS, Yang L, Manithody C, Rezaie AR. 2007a. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem 282:9251-9259. (Pubitemid 47093484)
5. Bae JS, Yang L, Manithody C, Rezaie AR. 2007b. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability enhancing to a barrier-protective response in endothelial cells. Blood 110:3909-3916. (Pubitemid 350248446)
6. Bae JS, Yang L, Rezaie AR. 2007c. Receptors of the protein C activation and activated protein C signaling pathways are co-localized in lipid rafts of endothelial cells. Proc Natl Acad Sci USA 104:2867-2872.
7. Camerer E, Huang W, Coughlin SR. 2000. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97:5255-5260. (Pubitemid 30313705)
8. Chang MC, Lin CP, Huang TF, Lan WH, Lin YL, Hsieh CC, Jeng JH. 1998. Thrombin-induced DNA synthesis of cultured human dental pulp cells is dependent on its proteolytic activity and modulated by prostaglandin E2. J Endod 24:709-713. (Pubitemid 128704275)
9. Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J. 2002. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: Role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90:1222-1230. (Pubitemid 34786908)
10. Chin AC, Vergnolle N, MacNaughton WK, Wallace JL, Hollenberg MD, Buret AG. 2003. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci USA 100:11104-11109. (Pubitemid 37140159)
11. Cirino G, Napoli C, Bucci M, Cicala C. 2000. Inflammation-coagulation network: Are serine protease receptors the knot? Trends Pharmacol Sci 21:170-172.
12. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. 1994. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 144:975-985. (Pubitemid 24160638)
13. Coughlin SR. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258-264.
14. Coughlin SR. 2001. Protease-activated receptors in vascular biology. Thromb Haemost 86:298-307. (Pubitemid 32663960)
15. Coughlin SR. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814. (Pubitemid 41716567)
16. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG. 2000. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-462.
17. Dejana E. 1996. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949-1953. (Pubitemid 26376280)
18. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. 1997. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326. (Pubitemid 27300299)
19. Drake WT, Lopes NN, Fenton JW II, Issekutz AC, Ueno A, Murakami K, Yamanouchi K, Watanabe M, Kondo T. 1992. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. Lab Invest 67:617-627.
20. Feistritzer C, Riewald M. 2005. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105:3178-3184. (Pubitemid 40504337)
21. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG. 2005. Activated protein C mediates novel lung endothelial barrier enhancement: Role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280:17286-17293. (Pubitemid 41389197)
22. Frenette PS, Wagner DD. 1996. Adhesion molecules-Part 1. N Engl J Med 334:1526-1529.
23. Garcia JG, Patterson C, Bahler C, Aschner J, Hart CM, English D. 1993. Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J Cell Physiol 156:541-549. (Pubitemid 23269871)
24. Grand RJ, Turnell AS, Grabham PW. 1996. Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368. (Pubitemid 26030120)
25. Grandaliano G, Valente AJ, Abboud HE. 1994. A novel biologic activity of thrombin: Stimulation of monocyte chemotactic protein production. J Exp Med 179:1737-1741. (Pubitemid 24129596)
26. Harlan JM, Winn RK. 2002. Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. Crit Care Med 30:S214-S219. (Pubitemid 34507993)
27. Howells GL, Macey M, Curtis MA, Stone SR. 1993. Peripheral blood lymphocytes express the platelet-type thrombin receptor. Br J Haematol 84:156-160. (Pubitemid 23158130)
28. Howells GL, Macey M, Murrell AM, Green AR, Curtis MA, Stone SR. 1994. Thrombin receptor expression and function in large granular lymphocyte proliferative disorders. Br J Haematol 88:383-388. (Pubitemid 24318189)
29. Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, Haskard DO, Nourshargh S. 2006. ICAM-2 mediates neutrophil transmigration in vivo: Evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood 107:4721-4727. (Pubitemid 43882622)
30. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. 1997. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506. (Pubitemid 27164077)
31. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Jr., Tam C, Coughlin SR. 1998. A dual thrombin receptor system for platelet activation. Nature 394:690-694. (Pubitemid 28389797)
32. Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, Kaplanski S, Farnarier C. 1998. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 92:1259-1267. (Pubitemid 28369039)
33. Kayanoki Y, Higashiyama S, Suzuki K, Asahi M, Kawata S, Matsuzawa Y, Taniguchi N. 1999. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells. Biochem Biophys Res Commun 259:50-55. (Pubitemid 29263992)
34. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620. (Pubitemid 33648192)
35. Klepfish A, Greco MA, Karpatkin S. 1993. Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 53:978-982. (Pubitemid 23119547)
36. Komarova YA, Mehta D, Malik AB. 2007. Dual regulation of endothelial junctional permeability. Sci STKE 2007:re8.
37. Ludwicka-Bradley A, Tourkina E, Suzuki S, Tyson E, Bonner M, Fenton JW II, Hoffman S, Silver RM, 2000. Thrombin up-regulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation. Am J Respir Cell Mol Biol 22:235-243. (Pubitemid 30351487)
38. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. 2001. Proteinase-activated receptors. Pharmacol Rev 53:245-282. (Pubitemid 32476117)
39. Majno G, Palade GE. 1961. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: An electronmicroscopic study. J Biophys Biochem Cytol 11:571-605.
40. McLaughlin JN, Patterson MM, Malik AB. 2007. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104:5662-5667. (Pubitemid 47175737)
41. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, Brass LF. 1997. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272:4043-4049. (Pubitemid 27078466)
42. Naldini A, Carney DH. 1996. Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell Immunol 172:35-42. (Pubitemid 26295660)
43. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF, Coughlin SR. 1992. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621.
44. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. 1991. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 87:229-236.
45. Nierodzik ML, Kajumo F, Karpatkin S. 1992. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 52:3267-3272.
46. Nystedt S, Emilsson K, Larsson AK, Strombeck B, Sundelin J. 1995. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 232:84-89.
47. Ossovskaya VS, Bunnett NW, de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P. 2004. Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 84:579-621. (Pubitemid 38365493)
48. Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, Van Obberghen-Schilling E. 1991. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 288:123-128.
49. Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR. 2001. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413:74-78. (Pubitemid 32843490)
50. Smith R, Jenkins A, Lourbakos A, Thompson P, Ramakrishnan V, Tomlinson J, Deshpande U, Johnson DA, Jones R, Mackie EJ, Pike RN. 2000. Evidence for the activation of PAR-2 by the sperm protease, acrosin: Expression of the receptor on oocytes. FEBS Lett 484:285-290.
51. Steinhoff M, Corvera CU, Thoma MS, Kong W, McAlpine BE, Caughey GH, Ansel JC, Bunnett NW. 1999. Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282-294. (Pubitemid 29370853)
52. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD. 2005. Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26:1-43. (Pubitemid 40209385)
53. Sugama Y, Tiruppathi C, Offakidevi K, Andersen TT, Fenton JW II, Malik AB. 1992. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion. J Cell Biol 119:935-944.
54. Suk K, Cha S. 1999. Thrombin-induced interleukin-8 production and its regulation by interferon-gamma and prostaglandin E2 in human monocytic U937 cells. Immunol Lett 67:223-227. (Pubitemid 29219768)
55. Ueno A, Murakami K, Yamanouchi K, Watanabe M, Kondo T. 1996. Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology 88:76-81. (Pubitemid 26166379)
56. Vergnolle N, Hollenberg MD, Wallace JL. 1999. Pro- and anti-inflammatory actions of thrombin: A distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol 126:1262-1268. (Pubitemid 29123764)
57. Vu TK, Hung DT, Wheaton VI, Coughlin SR. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068. (Pubitemid 121001193)
58. Weinstein JR, Gold SJ, Cunningham DD, Gall CM. 1995. Cellular localization of thrombin receptor mRNA in rat brain: Expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15:2906-2919.
59. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. 1998. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95:6642-6646. (Pubitemid 28278033)